Abraham A, Gyulai G, Mihaly J, Horvath A, Dobay O, Varga Z
J Pharm Anal. 2025; 14(12):101020.
PMID: 39881961
PMC: 11774939.
DOI: 10.1016/j.jpha.2024.101020.
Adak A, Castelletto V, de Mello L, Mendes B, Barrett G, Seitsonen J
ACS Appl Bio Mater. 2025; 8(1):803-813.
PMID: 39792083
PMC: 11752523.
DOI: 10.1021/acsabm.4c01635.
Mechesso A, Zhang W, Su Y, Xie J, Wang G
Probiotics Antimicrob Proteins. 2024; 17(1):15-34.
PMID: 39377976
DOI: 10.1007/s12602-024-10376-3.
Thi Phuong H, Ngan H, Thi H, Thi Thanh B, Dang T, Ho T
Protein J. 2024; 43(5):1025-1034.
PMID: 39190120
DOI: 10.1007/s10930-024-10231-y.
Conde-Torres D, Calvelo M, Rovira C, Pineiro A, Garcia-Fandino R
Comput Struct Biotechnol J. 2024; 25:61-74.
PMID: 38695015
PMC: 11061258.
DOI: 10.1016/j.csbj.2024.04.022.
Effect of CM15 on Supported Lipid Bilayer Probed by Atomic Force Microscopy.
Walsh O, Choi L, Sigdel K
Membranes (Basel). 2023; 13(11).
PMID: 37999350
PMC: 10672887.
DOI: 10.3390/membranes13110864.
Can BioSAXS detect ultrastructural changes of antifungal compounds in ?-an exploratory study.
Hilpert K, Rumancev C, Gani J, Collis D, Lopez-Perez P, Garamus V
Front Pharmacol. 2023; 14:1141785.
PMID: 37533629
PMC: 10393279.
DOI: 10.3389/fphar.2023.1141785.
Molecular Dynamics Simulation of Antimicrobial Peptide CM15 in and Model Bilayer Lipid.
Zaeifi D, Najafi A, Mirnejad R
Iran J Biotechnol. 2023; 21(2):e3344.
PMID: 37228629
PMC: 10203184.
DOI: 10.30498/ijb.2023.337246.3344.
Structure-activity relationships of antibacterial peptides.
Ciulla M, Gelain F
Microb Biotechnol. 2023; 16(4):757-777.
PMID: 36705032
PMC: 10034643.
DOI: 10.1111/1751-7915.14213.
Designed Multifunctional Peptides for Intracellular Targets.
Juretic D
Antibiotics (Basel). 2022; 11(9).
PMID: 36139975
PMC: 9495127.
DOI: 10.3390/antibiotics11091196.
Novel CA(1-7)M(2-9) Analogs: Synthesis, Characterization, and Antibacterial Evaluation.
Chetty T, Mhlongo J, Waddad A, Albericio F, de la Torre B
ACS Med Chem Lett. 2022; 13(8):1370-1377.
PMID: 35978681
PMC: 9377004.
DOI: 10.1021/acsmedchemlett.2c00270.
A Molecular Dynamics Study of Antimicrobial Peptide Interactions with the Lipopolysaccharides of the Outer Bacterial Membrane.
Sharma P, Ayappa K
J Membr Biol. 2022; 255(6):665-675.
PMID: 35960325
DOI: 10.1007/s00232-022-00258-6.
A novel hybrid peptide composed of LfcinB6 and KR-12-a4 with enhanced antimicrobial, anti-inflammatory and anti-biofilm activities.
Ajish C, Yang S, Kumar S, Kim E, Min H, Lee C
Sci Rep. 2022; 12(1):4365.
PMID: 35288606
PMC: 8921290.
DOI: 10.1038/s41598-022-08247-4.
Effective inhibition of Clostridioides difficile by the novel peptide CM-A.
Arthithanyaroj S, Chankhamhaengdecha S, Chaisri U, Aunpad R, Aroonnual A
PLoS One. 2021; 16(9):e0257431.
PMID: 34516580
PMC: 8437281.
DOI: 10.1371/journal.pone.0257431.
Recent Applications of Retro-Inverso Peptides.
Doti N, Mardirossian M, Sandomenico A, Ruvo M, Caporale A
Int J Mol Sci. 2021; 22(16).
PMID: 34445382
PMC: 8395423.
DOI: 10.3390/ijms22168677.
Controlling Peptide Function by Directed Assembly Formation: Mechanistic Insights Using Multiscale Modeling on an Antimicrobial Peptide-Drug-Membrane System.
Kohut G, Juhasz T, Queme-Pena M, Bosze S, Beke-Somfai T
ACS Omega. 2021; 6(24):15756-15769.
PMID: 34179620
PMC: 8223213.
DOI: 10.1021/acsomega.1c01114.
Overlapping Properties of the Short Membrane-Active Peptide BP100 With (i) Polycationic TAT and (ii) α-helical Magainin Family Peptides.
Mink C, Strandberg E, Wadhwani P, Melo M, Reichert J, Wacker I
Front Cell Infect Microbiol. 2021; 11:609542.
PMID: 33981626
PMC: 8107365.
DOI: 10.3389/fcimb.2021.609542.
A Synergic Potential of Antimicrobial Peptides against pv. .
Mariz-Ponte N, Regalado L, Gimranov E, Tassi N, Moura L, Gomes P
Molecules. 2021; 26(5).
PMID: 33800273
PMC: 7962642.
DOI: 10.3390/molecules26051461.
How Insertion of a Single Tryptophan in the N-Terminus of a Cecropin A-Melittin Hybrid Peptide Changes Its Antimicrobial and Biophysical Profile.
Ferreira A, Teixeira C, Sousa C, Bessa L, Gomes P, Gameiro P
Membranes (Basel). 2021; 11(1).
PMID: 33445476
PMC: 7826622.
DOI: 10.3390/membranes11010048.
Acylation of the antimicrobial peptide CAMEL for cancer gene therapy.
Song J, Ma P, Huang S, Wang J, Xie H, Jia B
Drug Deliv. 2020; 27(1):964-973.
PMID: 32611259
PMC: 8216477.
DOI: 10.1080/10717544.2020.1787556.